Class 4 caution in use-Omeprazole 40mg Powder for solution for infusion

Generics (U.K.) Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in specific batches of Omeprazole 40 mg Powder for solution for infusion do not contain the most up to date safety information.

MHRA Drug alert date: 12th November 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-viatris-uk-healthcare-ltd-omeprazole-40-mg-powder-for-solution-for-infusion-el-24-a-slash-54?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=b6521847-f0ea-4fbc-adc8-ba74059c9b3b&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information and stock control queries please contact:

Viatris UK Healthcare Limited Medical Information at +44 (0)1707 853 000 (select option 1) or info.uk@viatris.com. Customer Services can be reached at +44 (0)1707 853 000 (select option 2).